Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 19 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

32%

6 trials in Phase 3/4

Results Transparency

14%

1 of 7 completed trials have results

Key Signals

6 recruiting1 with results

Enrollment Performance

Analytics

N/A

6(33.3%)

Phase 2

5(27.8%)

Phase 4

4(22.2%)

Phase 3

2(11.1%)

Phase 1

1(5.6%)

18Total

N/A(6)

Phase 2(5)

Phase 4(4)

Phase 3(2)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (19)

Showing 19 of 19 trials

NCT05072314Phase 3Recruiting

Long-term Outcomes of Lidocaine Infusions for Post-Operative Pain (LOLIPOP) Trial

Role: collaborator

NCT05558605Not ApplicableRecruiting

Use of Artificial Intelligence-Guided Echocardiography to assIst cardiovascuLar Patient managEment

Role: collaborator

NCT05509153Phase 2Recruiting

A Randomised Controlled Trial, Of N-Acetyl Cysteine (NAC), for Premanifest Huntingtin Gene Expansion Carriers

Role: collaborator

NCT03382158Recruiting

International PPB/DICER1 Registry

Role: collaborator

NCT05967507Not ApplicableUnknown

Laryngoscopy for Neonatal and Infant Airway Management with Supplemental Oxygen At Different Flow Rates (OPTIMISE-2)

Role: collaborator

NCT06266104Not ApplicableRecruiting

Image Enhanced Endoscopy IBD

Role: lead

NCT04018040Not ApplicableCompleted

Vegetarian Diet in IBD

Role: collaborator

NCT05703620Not ApplicableRecruiting

REducing Sympathetic Activity Through Ultrasound-based Renal deneRvation in Excessive Cardiovascular Risk populaTions.

Role: lead

NCT03912909Phase 4Unknown

Effects of Sodium-glucose Co-transporter-2( SGLT-2 ) Inhibition on Sympathetic Nervous System Activity in Humans

Role: lead

NCT04478500Phase 3Unknown

Neuroinflammation in Hypertension Study

Role: lead

NCT04474899Phase 4Unknown

Sympathoinhibition as a Preferred Second Line Treatment of Obesity Related Hypertension

Role: lead

NCT04479813Phase 4Completed

Role of Sympathetic Activation in Ischemia Reperfusion Injury

Role: lead

NCT03945110Phase 1Completed

Intravesical Glycosaminoglycan Instillation and Urinary Tract Infection in Acute Spinal Cord Injury

Role: collaborator

NCT01138917Not ApplicableCompleted

A Multicenter Comparative Study of the ReCell Device and Autologous Split-thickness Meshed Skin Graft in the Treatment of Acute Burn Injuries

Role: collaborator

NCT01589549Phase 2Unknown

Mesenchymal Stromal Cells for Acute Graft Versus Host Disease

Role: collaborator

NCT01657110Phase 2Completed

Pilot Study to Evaluate Tea Tree Oil Gel for Facial Acne

Role: collaborator

NCT00620529Phase 4Completed

The Effects of Fish Oils on Blood Pressure, Heart Rate Variability and Liver Fat in the Polycystic Ovary Syndrome

Role: collaborator

NCT00371904Phase 2Unknown

Trial of Rituximab Given Pre-Transplant to Sensitised Live Donor Kidney Recipients

Role: collaborator

NCT00257764Phase 2Completed

Behavioural Intervention for Dysphagia in Acute Stroke

Role: lead

All 19 trials loaded